# Title

 Food and Drugs. PART 1310â€”RECORDS AND REPORTS OF LISTED CHEMICALS AND CERTAIN MACHINES; IMPORTATION AND EXPORTATION OF CERTAIN MACHINES


# ID

 CFR-2018-title21-vol9.Pt. 1310


# Structured Analysis Summary

| Type        | Values                                                                                                                                                                                                                                                                                                                                                                 |
|:------------|:-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Money       | [(12000.0, 'GBP')]                                                                                                                                                                                                                                                                                                                                                     |
| Constraints | ['at least', 'within', 'less than', 'exceeds', 'prior to', 'after', 'more than', 'greater than', 'later than', 'no less than', 'no later than', 'equal to', 'not to exceed', 'before', 'greater than or equal to']                                                                                                                                                     |
| Duration    | ['2.0 year', '15.0 day', '10.0 day', '1 year', '30 day', '30.0 day', '15 day', '5.0 day', '2 year', '60.0 day']                                                                                                                                                                                                                                                        |
| Condition   | ['if not', 'when', 'unless', 'subject to', 'until', 'not subject to', 'provided that', 'if', 'where']                                                                                                                                                                                                                                                                  |
| Entities    | ['United States', 'Bolivia', 'Chile', 'Pursuant', 'French Guiana', 'Canada', 'Written', 'Lugol', 'Inventory', 'Ecuador', 'Uruguay', 'Maintenance', 'Return', 'Removal', 'Acetone', 'Bulk', 'Brazil', 'Internal', 'Colombia', 'Argentina', 'Venezuela', 'Guyana', 'Peru', 'Pseudoephedrine', 'Panama', 'Such', 'Paraguay', 'Food', 'U.S', 'Sale', 'Iodine', 'Chemical'] |
| Date        | ['2007-06-22', '2000-07-24', '2011-05-02', '2005-02-14', '2003-06-30', '2007-08-31', '2007-08-24', '2018-01-04', '2010-07-29', '2011-07-05', '2018-01-02', '1997-12-03', '2017-08-14', '2001-12-17', '1997-07-12']                                                                                                                                                     |


# Structured Analysis With Context

 


## Money

| Money            | Context                                                                                                                     |
|:-----------------|:----------------------------------------------------------------------------------------------------------------------------|
| (12000.0, 'GBP') | (h) Domestic distribution of anhydrous hydrogen chloride weighing 12,000 pounds (net weight) or more in a single container. |


## Constraints

| Constraints              | Context                                                                                                                                         |
|:-------------------------|:------------------------------------------------------------------------------------------------------------------------------------------------|
| at least                 | Register following a proposal which shall be published at least  30 days prior to the final rule.                                               |
| prior to                 | which shall be published at least 30 days prior to  the final rule.                                                                             |
| within                   | petitioner of his decision and the reason therefor. within                                                                                      |
| after                    | (g) Within a reasonable period of time  after the receipt of the petition, the Administrator shall                                              |
| within                   | person to file written comments regarding the proposal within 30 days of the date of publication of                                             |
| after                    | kept by the regulated person for 2 years after  the date of the transaction.                                                                    |
| after                    | kept by the regulated person for two years after  the date of the transaction.                                                                  |
| more than                | (e) The regulated person with  more than one place of business where records are required                                                       |
| within                   | threshold or the cumulative amount for multiple transactions within a calendar month, to be utilized in determining                             |
| exceeds                  | or volume of a chemical mixture meets or exceeds the applicable quantitative threshold, the following rules apply:                              |
| exceeds                  | quantity of any of these chemicals equals or exceeds the threshold applicable to that chemical, then the                                        |
| after                    | DEA Divisional Office at the earliest practicable opportunity after the regulated person becomes aware of the circumstances                     |
| within                   | DEA Divisional Office as set forth in &#167;&#8201;1310.06 within 15 calendar days after the regulated person becomes                           |
| after                    | set forth in &#167;&#8201;1310.06 within 15 calendar days after the regulated person becomes aware of the circumstances                         |
| after                    | DEA Divisional Office at the earliest practicable opportunity after the regulated person becomes aware of the circumstances                     |
| after                    | DEA Divisional Office at the earliest practicable opportunity after the regulated person becomes aware of the circumstances                     |
| within                   | the DEA Diversion Control Division secure network application within 15 calendar days after becoming aware of the                               |
| after                    | Division secure network application within 15 calendar days after  becoming aware of the circumstances requiring the report.                    |
| within                   | the DEA Diversion Control Division secure network application within 15 calendar days after the order has been                                  |
| after                    | Division secure network application within 15 calendar days after  the order has been shipped by the seller.                                    |
| more than                | A report (DEA Form 452) may list  more than  one machine for a single transaction.                                                              |
| at least                 | the DEA Diversion Control Division secure network application, at least 15 calendar days before the anticipated arrival at                      |
| before                   | secure network application, at least 15 calendar days before the anticipated arrival at the port of entry                                       |
| within                   | importer who attempted to import the shipment must, within 5 business days of the denial, report to                                             |
| before                   | Diversion Control Division, Drug Enforcement Administration, on or before the 15th day of March of the year                                     |
| before                   | and information set forth in &#167;&#8201;1310.06(k), on or before the 15th day of each month following the                                     |
| more than                | of drug products when those packages contain not more than two solid dosage units or the equivalent of                                          |
| not to exceed            | equivalent of two dosage units in liquid form, not to exceed 10 milliliters of liquid per package, and not                                      |
| more than                | of drug products when those packages contain not more than two solid dosage units or the equivalent of                                          |
| after                    | that will take place  after  importation.                                                                                                       |
| within                   | receipt of a tableting or encapsulating machine, or within 10 calendar days after receipt of a written                                          |
| after                    | (1) Within 30 calendar days  after actual receipt of a tableting or encapsulating machine,                                                      |
| within                   | receipt of a tableting or encapsulating machine, or within 10 calendar days after receipt of a written                                          |
| after                    | (1) Within 30 calendar days  after actual receipt of a tableting or encapsulating machine,                                                      |
| after                    | that will take place  after importation; and any other information as the Administration                                                        |
| within                   | customs officer at the port of export, or within 10 calendar days after receipt of a written                                                    |
| after                    | (2) Within 30 calendar days  after the tableting or encapsulating machine is released by                                                        |
| within                   | customs officer at the port of export, or within 10 calendar days after receipt of a written                                                    |
| after                    | (2) Within 30 calendar days  after the tableting or encapsulating machine is released by                                                        |
| after                    | following the return at the earliest practicable opportunity after the regulated person becomes aware of the circumstances                      |
| at least                 | and other evidence of proof must consist of at least a signature of the purchaser, a driver's license                                           |
| greater than             | of one-fluid-ounce (30 milliliters) or less, and no greater than  one package per transaction.                                                  |
| greater than or equal to | conform to International Standards Organization specifications (with capacities greater than or equal to  2,500 gallons in a single container). |
| before                   | submits a proper application for registration on or before  July 12, 1997.                                                                      |
| before                   | submits a proper application for registration on or before December 3, 1997.The exemption will remain in effect                                 |
| before                   | receives a proper application for registration on or before  July 24, 2000.                                                                     |
| before                   | submits a proper application for registration on or before  December 17, 2001.                                                                  |
| before                   | for registration or application for exemption on or before  June 30, 2003.                                                                      |
| before                   | a properly completed application for registration on or before 30 days following the date of official DEA                                       |
| before                   | for registration or application for exemption on or before  February 14, 2005.                                                                  |
| before                   | a properly completed application for registration on or before 30 days following the date of official DEA                                       |
| before                   | mixture containing NPP pursuant to &#167;&#8201;1310.13 on or before  June 22, 2007.                                                            |
| before                   | a properly completed application for registration on or before 30 days following the date of official DEA                                       |
| before                   | for a chemical mixture containing iodine on or before  August 31, 2007.                                                                         |
| before                   | a properly completed application for registration on or before 30 days following the date of official Administration                            |
| before                   | for registration or application for exemption on or before  August 24, 2007.                                                                    |
| before                   | a properly completed application for registration on or before 30 days following the date of official DEA                                       |
| before                   | for registration or application for exemption on or before  July 29, 2010.                                                                      |
| before                   | a properly completed application for registration on or before 30 days following the date of official DEA                                       |
| before                   | and its salts pursuant to &#167;&#8201;1310.13 on or before  May 2, 2011.                                                                       |
| before                   | a properly completed application for registration on or before 30 days following the date of official DEA                                       |
| before                   | for registration or application for exemption on or before  July 5, 2011.                                                                       |
| before                   | a properly completed application for registration on or before 30 days following the date of official DEA                                       |
| before                   | of optical isomers, pursuant to &#167;&#8201;1310.13 on or before  August 14, 2017.                                                             |
| before                   | a properly completed application for registration on or before 30 days following the date of official DEA                                       |
| after                    | publish in the Federal Register his final order. after                                                                                          |
| within                   | application, and if not accepted, the reason therefor. within                                                                                   |
| after                    | (e) Within a reasonable period of time  after receipt of the application for reinstatement of the                                               |
| after                    | There after , the Administrator shall reinstate, revoke, or amend                                                                               |
| later than               | that the application for reinstatement is filed not later than 60 days after the publication of the final                                       |
| after                    | reinstatement is filed not later than 60 days after the publication of the final order removing the                                             |
| equal to                 | (c) Mixtures containing a listed chemical in concentrations  equal to or less than those specified in the &#8220;Table                          |
| less than                | a listed chemical in concentrations equal to or less than those specified in the &#8220;Table of Concentration Limits&#8221;                    |
| no less than             | upon request, such documentation for a period of no less than  two years.                                                                       |
| after                    | opaque solid protective, decorative, or functional adherent film after  application.                                                            |
| within                   | written comments on or objections to the order within 60 days of the date of publication of                                                     |
| after                    | There after , the Administrator shall reinstate, terminate, or amend                                                                            |
| after                    | publish in the Federal Register a final order. after                                                                                            |
| at least                 | mixture consisting of two or more chemical components, at least one of which is not a List I                                                    |
| within                   | acceptance or rejection of the application for filing. within                                                                                   |
| after                    | (e) Within a reasonable period of time  after the receipt of an application for an exemption                                                    |
| after                    | There after , the Administrator shall reinstate, terminate, or amend                                                                            |
| within                   | written comments on or objections to the order within 60 days of the date of publication of                                                     |
| after                    | There after , the Administrator shall reinstate, terminate, or amend                                                                            |
| greater than             | Changes include those  greater than the range of concentration given in the application                                                         |
| at least                 | DEA must be notified of reformulation  at least 30 days in advance of marketing the reformulated                                                |
| at least                 | DEA must be notified of any changes  at least 60 days in advance of the effective date                                                          |
| within                   | applicant of acceptance or non-acceptance of the application. within                                                                            |
| after                    | (d) Within a reasonable period of time  after the receipt of a completed application for an                                                     |
| after                    | There after , the Administrator shall reinstate, revoke, or amend                                                                               |
| no later than            | A request for certification must be submitted  no later than fifteen calendar days before the proposed sale is                                  |
| before                   | be submitted no later than fifteen calendar days before  the proposed sale is to take place.                                                    |
| within                   | in the illegal manufacture of a controlled substance. within                                                                                    |
| within                   | DEA also will provide,  within fifteen calendar days of receiving a request for                                                                 |
| within                   | The prospective bidder and end-user may,  within thirty calendar days of receipt of notification of                                             |
| within                   | Thereafter,  within a reasonable time, the Administrator will withdraw or                                                                       |
| within                   | DEA also will provide,  within fifteen calendar days of withdrawal of an existing                                                               |
| within                   | The bidder and end-user may,  within thirty calendar days of receipt of notification of                                                         |
| within                   | Thereafter,  within a reasonable time, the Administrator will withdraw or                                                                       |


## Duration

| Duration   | Context                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
|:-----------|:-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 30.0 day   | (a) List I chemicals                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
|            |           (b) List II chemicals:                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
|            |           (c) The Administrator may add or delete a substance as a listed chemical by publishing a final rule in the Federal Register following a proposal which shall be published at least 30 days prior to the final rule.                                                                                                                                                                                                                                                                                                                                                        |
| 30.0 day   | The Administrator shall permit any interested person to file written comments regarding the proposal within 30 days of the date of publication of his order in the Federal Register.                                                                                                                                                                                                                                                                                                                                                                                                 |
| 2.0 year   | (a) Every record required to be kept subject to &#167;&#8201;1310.03 for a List I chemical, a tableting machine, or an encapsulating machine shall be kept by the regulated person for 2 years after the date of the transaction.                                                                                                                                                                                                                                                                                                                                                    |
| 2 year     | (b) Every record required to be kept subject to Section 1310.03 for List II chemical shall be kept by the regulated person for two years after the date of the transaction.                                                                                                                                                                                                                                                                                                                                                                                                          |
| 15.0 day   | The regulated person must file a written report of the transaction(s) with the Special Agent in Charge of the DEA Divisional Office as set forth in &#167;&#8201;1310.06 within 15 calendar days after the regulated person becomes aware of the circumstances of the event.                                                                                                                                                                                                                                                                                                         |
| 15.0 day   | The regulated person must also file a complete and accurate DEA Form 107, in accordance with &#167;&#8201;1310.06(d), with the Administration through the DEA Diversion Control Division secure network application within 15 calendar days after becoming aware of the circumstances requiring the report.                                                                                                                                                                                                                                                                          |
| 15.0 day   | The regulated person also must file a report of the transaction (on DEA Form 452) with the Administration through the DEA Diversion Control Division secure network application within 15 calendar days after the order has been shipped by the seller.                                                                                                                                                                                                                                                                                                                              |
| 15.0 day   | (1) Each regulated person who imports or exports a tableting machine, or encapsulating machine, must file a report of such importation or exportation on DEA Form 452 with the Administration through the DEA Diversion Control Division secure network application, at least 15 calendar days before the anticipated arrival at the port of entry or port of export.                                                                                                                                                                                                                |
| 5.0 day    | In the event that a shipment of tableting or encapsulating machine(s) has been denied release by a customs officer at the port of entry for any reason, the importer who attempted to import the shipment must, within 5 business days of the denial, report to the Administration that the shipment was denied, the basis for denial, and such other information as is required by &#167;&#8201;1310.06(g).                                                                                                                                                                         |
| 15.0 day   | In such circumstances, the regulated person may proceed with the release of the tableting machines or encapsulating machines upon receipt of a transaction identification number for the refiled and amended DEA Form 452 without regard to the 15-day advance filing requirement in paragraph (c)(1) of this section, so long as the article is otherwise cleared for entry under U.S. customs laws.                                                                                                                                                                                |
| 30.0 day   | (f) Except as provided in paragraph (g) of this section, the following distributions to nonregulated persons, and the following export transactions, are not subject to the reporting requirements in &#167;&#8201;1310.03(c):                                                                                                                                                                                                                                                                                                                                                       |
|            |           (1) Distributions of sample packages of drug products when those packages contain not more than two solid dosage units or the equivalent of two dosage units in liquid form, not to exceed 10 milliliters of liquid per package, and not more than one package is distributed to an individual or residential address in any 30-day period.                                                                                                                                                                                                                                |
| 30.0 day   | (1) Within 30 calendar days after actual receipt of a tableting or encapsulating machine, or within 10 calendar days after receipt of a written request by the Administration to the importer, whichever is sooner, the importer must file a report with the Administration (on DEA Form 452) specifying the particulars of the transaction utilizing the DEA Diversion Control Division secure network application.                                                                                                                                                                 |
| 10.0 day   | (1) Within 30 calendar days after actual receipt of a tableting or encapsulating machine, or within 10 calendar days after receipt of a written request by the Administration to the importer, whichever is sooner, the importer must file a report with the Administration (on DEA Form 452) specifying the particulars of the transaction utilizing the DEA Diversion Control Division secure network application.                                                                                                                                                                 |
| 30.0 day   | (2) Within 30 calendar days after the tableting or encapsulating machine is released by a customs officer at the port of export, or within 10 calendar days after receipt of a written request by the Administration to the exporter, whichever is sooner, the exporter must file a report with the Administration (on DEA Form 452) through the DEA Diversion Control Division secure network application specifying the particulars of the transaction.                                                                                                                            |
| 10.0 day   | (2) Within 30 calendar days after the tableting or encapsulating machine is released by a customs officer at the port of export, or within 10 calendar days after receipt of a written request by the Administration to the exporter, whichever is sooner, the exporter must file a report with the Administration (on DEA Form 452) through the DEA Diversion Control Division secure network application specifying the particulars of the transaction.                                                                                                                            |
| 30.0 day   | A temporary exemption from the registration requirement will also be provided for these persons, provided that DEA receives a properly completed application for registration on or before 30 days following the date of official DEA notification that the application for exemption has not been approved.                                                                                                                                                                                                                                                                         |
| 30.0 day   | A temporary exemption from the registration requirement will also be provided for these persons, provided that DEA receives a properly completed application for registration on or before 30 days following the date of official DEA notification that the application for exemption has not been approved.                                                                                                                                                                                                                                                                         |
| 30.0 day   | A temporary exemption from the registration requirement will also be provided for those persons whose application for exemption are denied, provided that DEA receives a properly completed application for registration on or before 30 days following the date of official DEA notification that the application for exemption has been denied.                                                                                                                                                                                                                                    |
| 30.0 day   | A temporary exemption from the registration requirement will also be provided for these persons, provided that the Administration receives a properly completed application for registration on or before 30 days following the date of official Administration notification that the application for exemption has not been approved.                                                                                                                                                                                                                                               |
| 30.0 day   | A temporary exemption from the registration requirement will also be provided for these persons, provided that DEA receives a properly completed application for registration on or before 30 days following the date of official DEA notification that the application for exemption has not been approved.                                                                                                                                                                                                                                                                         |
| 30.0 day   | A temporary exemption from the registration requirement will also be provided for those persons whose applications for exemption are denied, provided that DEA receives a properly completed application for registration on or before 30 days following the date of official DEA notification that the application for exemption has been denied.                                                                                                                                                                                                                                   |
| 30.0 day   | A temporary exemption from the registration requirement will also be provided for those persons whose applications for exemption are denied, provided that DEA receives a properly completed application for registration on or before 30 days following the date of official DEA notification that the application for exemption has been denied.                                                                                                                                                                                                                                   |
| 30.0 day   | A temporary exemption from the registration requirement will also be provided for those persons whose applications are denied, provided that DEA receives a properly completed application for registration on or before 30 days following the date of official DEA notification that the application for exemption has not been approved.                                                                                                                                                                                                                                           |
| 30.0 day   | A temporary exemption from the registration requirement will also be provided for those persons whose applications for exemption are denied, provided that the DEA receives a properly completed application for registration on or before 30 days following the date of official DEA notification that the application for exemption has been denied.                                                                                                                                                                                                                               |
| 60.0 day   | (f) Unless the Administrator has evidence that the drug product is being diverted, as determined by applying the factors set forth in paragraph (a) of this section, and the Administrator so notifies the applicant, transactions involving a specific drug product will not be considered regulated transactions during the following periods:                                                                                                                                                                                                                                     |
|            |           (1) While a bonafide application for reinstatement of exemption under paragraph (d) of this section for the specific drug product is pending resolution, provided that the application for reinstatement is filed not later than 60 days after the publication of the final order removing the exemption; and                                                                                                                                                                                                                                                              |
|            |           (2) For a period of 60 days following the Administrator's denial of an application for reinstatement.                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
| 60.0 day   | (f) Unless the Administrator has evidence that the drug product is being diverted, as determined by applying the factors set forth in paragraph (a) of this section, and the Administrator so notifies the applicant, transactions involving a specific drug product will not be considered regulated transactions during the following periods:                                                                                                                                                                                                                                     |
|            |           (1) While a bonafide application for reinstatement of exemption under paragraph (d) of this section for the specific drug product is pending resolution, provided that the application for reinstatement is filed not later than 60 days after the publication of the final order removing the exemption; and                                                                                                                                                                                                                                                              |
|            |           (2) For a period of 60 days following the Administrator's denial of an application for reinstatement.                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
| 2 year     | (1) Chemical mixtures that are distributed directly to an incinerator for destruction or directly to an authorized waste recycler or reprocessor where such distributions are documented on United States Environmental Protection Agency Form 8700-22; persons distributing the mixture to the incinerator or recycler must maintain and make available to agents of the Administration, upon request, such documentation for a period of no less than two years.                                                                                                                   |
| 60.0 day   | The Administrator shall permit any interested party to file written comments on or objections to the order within 60 days of the date of publication of the order in the Federal Register.                                                                                                                                                                                                                                                                                                                                                                                           |
| 60.0 day   | The Administrator shall permit any interested party to file written comments on or objections to the order within 60 days of the date of publication of the order in the Federal Register.                                                                                                                                                                                                                                                                                                                                                                                           |
| 30.0 day   | DEA must be notified of reformulation at least 30 days in advance of marketing the reformulated mixture.                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| 60.0 day   | DEA must be notified of any changes at least 60 days in advance of the effective date for the change.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
| 15 day     | A request for certification must be submitted no later than fifteen calendar days before the proposed sale is to take place.                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
| 15 day     | In order to facilitate the sale of chemicals from Federal departments' or agencies' stocks, Federal departments or agencies may wish to submit requests as far in advance of the fifteen calendar days as possible.                                                                                                                                                                                                                                                                                                                                                                  |
| 15 day     | (c) Within fifteen calendar days of receipt of a request for certification, the Administrator will certify in writing to the head of the Federal department or agency that there is, or is not, reasonable cause to believe that the sale of the specific chemical to the specific bidder and end-user would result in the illegal manufacture of a controlled substance.                                                                                                                                                                                                            |
| 1 year     | (d) If the Administrator certifies to the head of a Federal department or agency that there is no reasonable cause to believe that the sale of a specific chemical to a prospective bidder and end-user will result in the illegal manufacture of a controlled substance, that certification will be effective for one year from the date of issuance with respect to further sales of the same chemical to the same prospective bidder and end-user, unless the Administrator notifies the head of the Federal department or agency in writing that the certification is withdrawn. |
| 15 day     | DEA also will provide, within fifteen calendar days of receiving a request for certification from a Federal department or agency, the same written notice to the prospective bidder and end-user, and this notice also will contain a statement of the legal and factual basis for the refusal of certification.                                                                                                                                                                                                                                                                     |
| 30 day     | The prospective bidder and end-user may, within thirty calendar days of receipt of notification of the refusal, submit written comments or written objections to the Administrator's refusal.                                                                                                                                                                                                                                                                                                                                                                                        |
| 15 day     | DEA also will provide, within fifteen calendar days of withdrawal of an existing certification, the same written notice to the bidder and end-user, and this notice also will contain a statement of the legal and factual basis for the withdrawal.                                                                                                                                                                                                                                                                                                                                 |
| 30 day     | The bidder and end-user may, within thirty calendar days of receipt of notification of the withdrawal of the existing certification, submit written comments or written objections to the Administrator's withdrawal.                                                                                                                                                                                                                                                                                                                                                                |


## Condition

| Condition      | Context                                                                                                                                                       |
|:---------------|:--------------------------------------------------------------------------------------------------------------------------------------------------------------|
| subject to     | the Drug Enforcement Administration as the listed chemicals subject to the provisions of this part and parts 1309                                             |
| if             | The Administrator need not accept a petition  if any of the requirements prescribed in paragraph (e)                                                          |
| if             | or delete a substance as a listed chemical. if                                                                                                                |
| subject to     | (a) Every record required to be kept  subject to &#167;&#8201;1310.03 for a List I chemical, a tableting                                                      |
| subject to     | (b) Every record required to be kept  subject to Section 1310.03 for List II chemical shall be                                                                |
| where          | kept at the regulated person's place of business where the transaction occurred, except that records may be                                                   |
| if             | a single, central location of the regulated person if  the regulated person has not                                                                           |
| where          | person with more than one place of business where records are required to be kept shall devise                                                                |
| subject to     | Sales of these products at retail are  subject to  the requirements of part 1314 of this chapter.                                                             |
| subject to     | All such transactions, regardless of size, are  subject to recordkeeping and reporting requirements as set forth in                                           |
| if             | to that chemical, then the transaction is regulated. if                                                                                                       |
| unless         | furnished to the regulated person by the Administration unless  the transaction is approved by the Administration.                                            |
| until          | their agent or the common or contract carrier until the shipment has been released by the customs                                                             |
| if             | regulated person should also consider whether the spec if ic listed chemical was a likely candidate for                                                       |
| when           | the regulated person making the report is located when  the order is placed with the seller.                                                                  |
| until          | The report will not be deemed filed  until a transaction identification number has been issued by                                                             |
| until          | The report will not be deemed filed  until a transaction identification number has been issued by                                                             |
| if             | or encapsulating machine may be imported or exported if  that machine is needed for medical, commercial, scient                                               |
| unless         | furnished to the regulated person by the Administration unless  the transaction is approved by the Administration.                                            |
| provided that  | an aggregate amount for the entire business entity provided that they inform the DEA of which method they                                                     |
| not subject to | nonregulated persons, and the following export transactions, are not subject to the reporting requirements in &#167;&#8201;1310.03(c): (1) Distributions of   |
| when           | (1) Distributions of sample packages of drug products when those packages contain not more than two solid                                                     |
| subject to     | and 1313.32 of this chapter or which are subject to  a waiver granted under &#167;&#8201;1313.21 of this chapter.                                             |
| if             | of this section for an individual regulated person if the Administrator finds that drug products distributed by                                               |
| if             | ), and,  if required, DEA registration number of each party to                                                                                                |
| if             | (3) The quantity, chemical name, and,  if  applicable, National Drug Code (NDC) number.                                                                       |
| if             | or encapsulating machine (including make, model, serial number, if any, and whether the machine is manual or                                                  |
| if             | section, normal business records will be considered adequate if they contain the information listed in paragraph (a)                                          |
| where          | section, the basis for making the report, and, where obtainable, the registration number of the other party,                                                  |
| if             | by &#167;&#8201;1310.05(a) must include the information as spec if ied by paragraph (a) of this section, the                                                  |
| if             | ), and,  if applicable, DEA registration number of each party to                                                                                              |
| if             | chemical name, and National Drug Code (NDC) number, if  applicable or                                                                                         |
| if not         | National Drug Code (NDC) number, if applicable or if not  the form of packaging of the listed chemical.                                                       |
| if             | of the import broker or forwarding agent,  if any; (ii) A description of each machine (including                                                              |
| if             | of the import broker or forwarding agent,  if any; (ii) A description of each machine (including                                                              |
| if             | (vi) Any proposed changes in ident if ying information of the imported machines (e.g., name,                                                                  |
| if             | of the export broker ( if applicable); (ii) A description of each machine (including                                                                          |
| where          | of the consignee in the country  where the shipment is destined; the name(s)/business name(s) and                                                             |
| if             | of each machine (including make, model, serial number, if any, and whether the machine is manual or                                                           |
| where          | date on which release was denied; the port where the denial of release was issued from; and                                                                   |
| where          | at the final destination; the port of entry where the machine(s) were actually released by a customs                                                          |
| if             | machine imported (including make, model, and serial number, if  any); any changes in ident                                                                    |
| if             | machine imported (including make, model, and serial number, if  any); any changes in ident                                                                    |
| until          | The report will not be deemed filed  until  the Administration has issued a transaction identification number.                                                |
| if             | encapsulating machine released (including make, model, serial number, if any, and whether the machine is manual or                                            |
| if             | (For each listed chemical,  if the prior period's ending inventory has not previously                                                                         |
| unless         | for internal consumption during the preceding calendar year, unless  the chemical is produced solely for internal consumption.                                |
| when           | shall identify the specific isomer, salt or ester when applicable but quantitative data shall be reported as                                                  |
| if             | (4) Chemical name, National Drug Code (NDC) number,  if  applicable, and total amount shipped.                                                                |
| if             | the other party present documents which would ver if y the identity, or registration status                                                                   |
| if             | Commerce or the local Better Business Bureau, or, if  the business entity is a registrant, by ver                                                             |
| when           | verify the claimed agency status of the representative. when                                                                                                  |
| subject to     | the other party to the transaction may be subject to the specific penalties provided for violations of law                                                    |
| unless         | person must ensure that shipments are not made unless the order is placed by an authorized agent                                                              |
| unless         | that contain acetone, ethyl ether, 2-butanone, and/or toluene, unless regulated because of being formulated with other List                                   |
| provided that  | product is temporarily exempted from the registration requirement, provided that the person submits a proper application for registration                     |
| until          | for each person who has made such application until  the Administration has approved or denied that application.                                              |
| provided that  | chapter is temporarily exempted from the registration requirement, provided that the person submits a proper application for registration                     |
| until          | for each person who has made such application until  the Administration has approved or denied that application.                                              |
| provided that  | GBL is temporarily exempted from the registration requirement, provided that the DEA receives a proper application for registration                           |
| until          | for each person who has made such application until  the Administration has approved or denied that application.                                              |
| provided that  | salts), is temporarily exempted from the registration requirement, provided that the person submits a proper application for registration                     |
| until          | for each person who has made such application until  the Administration has approved or denied that application.                                              |
| provided that  | 1310.13, is temporarily exempted from the registration requirement, provided that DEA receives a proper application for registration or                       |
| until          | for each person who has made such application until  the Administration has approved or denied that application.                                              |
| provided that  | requirement will also be provided for these persons, provided that DEA receives a properly completed application for registration                             |
| until          | exemption for such persons will remain in effect until  DEA takes final action on their registration application.                                             |
| provided that  | 1310.13, is temporarily exempted from the registration requirement, provided that DEA receives a proper application for registration or                       |
| until          | for each person who has made such application until  the Administration has approved or denied that application.                                              |
| provided that  | requirement will also be provided for these persons, provided that DEA receives a properly completed application for registration                             |
| until          | exemption for such persons will remain in effect until  DEA takes final action on their registration application.                                             |
| provided that  | &#167;&#8201;1310.12, is temporarily exempted from the registration requirement, provided that DEA receives a proper application for registration or          |
| until          | for each person who has made such application until  the Administration has approved or denied that application.                                              |
| provided that  | those persons whose application for exemption are denied, provided that DEA receives a properly completed application for registration                        |
| until          | exemption for such persons will remain in effect until  DEA takes final action on their registration application.                                             |
| provided that  | 1310.13, is temporarily exempted from the registration requirement, provided that the Administration receives a proper application for registration           |
| until          | for each person who has made such application until  the Administration has approved or denied that application.                                              |
| provided that  | requirement will also be provided for these persons, provided that the Administration receives a properly completed application for                           |
| until          | exemption for such persons will remain in effect until the Administration takes final action on their registration                                            |
| provided that  | 1310.13, is temporarily exempted from the registration requirement, provided that DEA receives a properly completed application for registration              |
| until          | for each person who has made such application until  the Administration has approved or denied that application.                                              |
| provided that  | requirement will also be provided for these persons, provided that DEA receives a properly completed application for registration                             |
| until          | exemption for such persons will remain in effect until  DEA takes final action on their registration application.                                             |
| provided that  | 1310.13, is temporarily exempted from the registration requirement, provided that DEA receives a properly completed application for registration              |
| until          | for each person who has made such application until  the Administration has approved or denied that application.                                              |
| provided that  | those persons whose applications for exemption are denied, provided that DEA receives a properly completed application for registration                       |
| until          | exemption for such persons will remain in effect until  DEA takes final action on their registration application.                                             |
| provided that  | &#167;&#8201;1310.12, is temporarily exempted from the registration requirement, provided that DEA receives a properly completed application for registration |
| until          | for each person who has made such application until  the Administration has approved or denied that application.                                              |
| provided that  | those persons whose applications for exemption are denied, provided that DEA receives a properly completed application for registration                       |
| until          | exemption for such persons will remain in effect until  DEA takes final action on their registration application.                                             |
| provided that  | 1310.13, is temporarily exempted from the registration requirement, provided that DEA receives a properly completed application for registration              |
| until          | for each person who has made such application until  the Administration has approved or denied that application.                                              |
| provided that  | provided for those persons whose applications are denied, provided that DEA receives a properly completed application for registration                        |
| until          | exemption for such persons will remain in effect until  DEA takes final action on their registration application.                                             |
| provided that  | &#167;&#8201;1310.12, is temporarily exempted from the registration requirement, provided that the DEA receives a properly completed application for          |
| until          | for each person who has made such application until  the Administration has approved or denied that application.                                              |
| provided that  | those persons whose applications for exemption are denied, provided that the DEA receives a properly completed application for                                |
| until          | exemption for such persons will remain in effect until the DEA takes final action on their registration                                                       |
| unless         | of drugs for which evidence of diversion exists unless there is evidence, based on the pattern of                                                             |
| if not         | his acceptance or non-acceptance of his application, and if not  accepted, the reason therefor.                                                               |
| until          | shall immediately suspend the effectiveness of the order until he may reconsider the application in light of                                                  |
| unless         | the Administrator's denial of an application for reinstatement. unless                                                                                        |
| provided that  | for the specific drug product is pending resolution, provided that the application for reinstatement is filed not later                                       |
| where          | directly to an authorized waste recycler or reprocessor where such distributions are documented on United States Environmental                                |
| if             | to add any additional substances except a thinner if  needed in certain cases.                                                                                |
| until          | shall immediately suspend the effectiveness of the order until he may reconsider the order in light of                                                        |
| if             | information: (1) The name, address, and registration number, if any, of the applicant; (2) The date of                                                        |
| if             | information: (1) The name, address, and registration number, if any, of the applicant; (2) The date of                                                        |
| if             | information: (1) The name, address, and registration number, if any, of the applicant; (2) The date of                                                        |
| if             | of all non-listed chemicals with respective concentration ranges. if                                                                                          |
| if             | properties of the mixture and how they d if fer from the properties of the listed chemical                                                                    |
| if             | the application that he deems necessary for determining if  the application should be granted.                                                                |
| if             | Administrator is not required to accept an application if any information required pursuant to paragraph (c) of                                               |
| until          | Administrator may suspend the effectiveness of the order until he has reconsidered the application in light of                                                |
| until          | Administrator may suspend the effectiveness of the order until he has reconsidered the order in light of                                                      |
| if             | A new application will be required only  if reformulation results in a new product having a                                                                   |
| if             | is exempt from part 1314 of this chapter if the Administrator determines that the product cannot be                                                           |
| if             | the application that he deems necessary for determining if  the application should be granted.                                                                |
| if             | Administrator is not required to accept an application if any of the information required in paragraph (b)                                                    |
| if             | legal authority under which the order is based. if                                                                                                            |
| until          | shall immediately suspend the effectiveness of the order until he may reconsider the application in light of                                                  |
| unless         | used in the manufacture of a controlled substance, unless the Administrator certifies in writing to the head                                                  |
| where          | and address of the prospective end-user, in cases where a sale is being brokered; (4) Point(s) of                                                             |
| where          | and address of the prospective end-user, in cases where a sale is being brokered; (4) Point(s) of                                                             |
| if             | (d) If the Administrator cert if ies to the head of a Federal department                                                                                      |
| unless         | chemical to the same prospective bidder and end-user, unless the Administrator notifies the head of the Federal                                               |
| if             | cause to believe the sale of the spec if ic chemical to a spec                                                                                                |
| if             | reasonable cause to believe that an existing cert if ication should be withdrawn, DEA will provide written                                                    |


## Entities

| Entities        | Context                                                                                                                                                                 |
|:----------------|:------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Food            | Food  and Drugs.                                                                                                                                                        |
| U.S             | and (ii) Uses or attempts to use the U.S . Postal Service or any private or commercial                                                                                  |
| U.S             | and (ii) Uses or attempts to use the U.S . Postal Service or any private or commercial                                                                                  |
| Maintenance     | Maintenance  of records.                                                                                                                                                |
| Written         | Written notification must be submitted by registered or certified                                                                                                       |
| Acetone         | threshold is not applicable to domestic sales of Acetone , 2-Butanone (MEK), and Toluene.                                                                               |
| Iodine          | manganese hypophosphite, magnesium hypophosphite, and sodium hypophosphite) (vi) Iodine (vii) N-phenethyl-4-piperidone (NPP) (viii) Pseudoephedrine, its salts, optical |
| Pseudoephedrine | sodium hypophosphite) (vi) Iodine (vii) N-phenethyl-4-piperidone (NPP) (viii) Pseudoephedrine , its salts, optical isomers, and salts of                                |
| U.S             | the article is otherwise cleared for entry under U.S . customs laws.                                                                                                    |
| Bulk            | Bulk manufacturers that produce a listed chemical solely for                                                                                                            |
| Internal        | Internal consumption includes (but is not limited to) quantities                                                                                                        |
| Food            | Food and Drug Administration regulations relating to the distribution                                                                                                   |
| Return          | (h)  Return  information.                                                                                                                                               |
| U.S             | otherwise deemed undeliverable may be returned to the U.S . exporter of record.                                                                                         |
| United States   | Returns to third parties in the  United States  will be regarded as imports.                                                                                            |
| Inventory       | Inventory does not include waste material for destruction, material                                                                                                     |
| Chemical        | (4)  Chemical name, National Drug Code (NDC) number, if applicable,                                                                                                     |
| U.S             | trade publications, confirmation through foreign subsidiaries of the U.S . regulated person, verification through the country of                                        |
| Pursuant        | Pursuant to 21 U.S.C. 802(39)(A)(iii), regulation of the following                                                                                                      |
| Argentina       | and international transactions to the following countries: (1) Argentina (2) Bolivia (3) Brazil (4) Chile (5) Colombia                                                  |
| Bolivia         | transactions to the following countries: (1) Argentina (2) Bolivia (3) Brazil (4) Chile (5) Colombia (6) Ecuador                                                        |
| Brazil          | the following countries: (1) Argentina (2) Bolivia (3) Brazil (4) Chile (5) Colombia (6) Ecuador (7) French                                                             |
| Chile           | countries: (1) Argentina (2) Bolivia (3) Brazil (4) Chile (5) Colombia (6) Ecuador (7) French Guiana (8)                                                                |
| Colombia        | Argentina (2) Bolivia (3) Brazil (4) Chile (5) Colombia (6) Ecuador (7) French Guiana (8) Guyana (9)                                                                    |
| Ecuador         | Bolivia (3) Brazil (4) Chile (5) Colombia (6) Ecuador (7) French Guiana (8) Guyana (9) Panama (10)                                                                      |
| French Guiana   | Brazil (4) Chile (5) Colombia (6) Ecuador (7) French Guiana (8) Guyana (9) Panama (10) Paraguay (11) Peru                                                               |
| Guyana          | (5) Colombia (6) Ecuador (7) French Guiana (8) Guyana (9) Panama (10) Paraguay (11) Peru (12) Suriname                                                                  |
| Panama          | (6) Ecuador (7) French Guiana (8) Guyana (9) Panama (10) Paraguay (11) Peru (12) Suriname (13) Uruguay                                                                  |
| Paraguay        | (7) French Guiana (8) Guyana (9) Panama (10) Paraguay (11) Peru (12) Suriname (13) Uruguay (14) Venezuela                                                               |
| Peru            | Guiana (8) Guyana (9) Panama (10) Paraguay (11) Peru (12) Suriname (13) Uruguay (14) Venezuela (c) Domestic                                                             |
| Uruguay         | Panama (10) Paraguay (11) Peru (12) Suriname (13) Uruguay (14) Venezuela (c) Domestic transactions of Methyl Isobutyl                                                   |
| Venezuela       | Paraguay (11) Peru (12) Suriname (13) Uruguay (14) Venezuela                                                                                                            |
|                 |           (c) Domestic transactions of Methyl Isobutyl Ketone (MIBK).                                                                                                   |
| United States   | of Methyl Isobutyl Ketone (MIBK) destined for the United States .                                                                                                       |
| Canada          | transfer of Methyl Isobutyl Ketone (MIBK) destined for Canada  or any country outside of the Western Hemisphere.                                                        |
| Lugol           | (f) Domestic and international transactions of  Lugol 's Solution (consisting of 5 percent iodine and                                                                   |
| Removal         | Removal of the exemption of drugs distributed under the                                                                                                                 |
| Chemical        | (1)  Chemical mixtures that are distributed directly to an incinerator                                                                                                  |
| United States   | or reprocessor where such distributions are documented on United States Environmental Protection Agency Form 8700-22; persons distributing the                          |
| U.S             | secret or confidential and entitled to protection under U.S . laws restricting the public disclosure of such                                                            |
| Food            | be lawfully marketed or distributed under the Federal, Food , Drug, and Cosmetic Act.                                                                                   |
| U.S             | secret or confidential and entitled to protection under U.S . laws restricting the public disclosure of such                                                            |
| Sale            | Sale by Federal departments or agencies of chemicals which                                                                                                              |
| Such            | Such affirmation of the original refusal will constitute a                                                                                                              |
| Such            | Such affirmation of the original withdrawal of the existing                                                                                                             |


## Date

| Date       | Context                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
|:-----------|:-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 2018-01-02 | (1) Listed chemicals for which no thresholds have been established:                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
|            |           (i) Alpha-phenylacetoacetonitrile and its salts, optical isomers, and salts of optical isomers (APAAN)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
|            |           (ii) Ephedrine, its salts, optical isomers, and salts of optical isomers;                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
|            |           (iii) Ergocristine and its salts                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
|            |           (iv) Gamma-Butyrolactone (Other names include: GBL; Dihydro-2(3H)-furanone; 1,2-Butanolide; 1,4-Butanolide; 4-Hydroxybutanoic acid lactone; gamma-hydroxybutyric acid lactone)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|            |           (v) Hypophosphorous acid and its salts (including ammonium hypophosphite, calcium hypophosphite, iron hypophosphite, potassium hypophosphite, manganese hypophosphite, magnesium hypophosphite, and sodium hypophosphite)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
|            |           (vi) Iodine                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
|            |           (vii) N-phenethyl-4-piperidone (NPP)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
|            |           (viii) Pseudoephedrine, its salts, optical isomers, and salts of optical isomers                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
|            |           (ix) Phenylpropanolamine, its salts, optical isomers, and salts of optical isomers                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
|            |           (x) Red phosphorus                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
|            |           (xi) White phosphorus (Other names: Yellow Phosphorus)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
|            |           (2) [Reserved]                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
| 2018-01-04 | (1) Listed chemicals for which no thresholds have been established:                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
|            |           (i) Alpha-phenylacetoacetonitrile and its salts, optical isomers, and salts of optical isomers (APAAN)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
|            |           (ii) Ephedrine, its salts, optical isomers, and salts of optical isomers;                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
|            |           (iii) Ergocristine and its salts                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
|            |           (iv) Gamma-Butyrolactone (Other names include: GBL; Dihydro-2(3H)-furanone; 1,2-Butanolide; 1,4-Butanolide; 4-Hydroxybutanoic acid lactone; gamma-hydroxybutyric acid lactone)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|            |           (v) Hypophosphorous acid and its salts (including ammonium hypophosphite, calcium hypophosphite, iron hypophosphite, potassium hypophosphite, manganese hypophosphite, magnesium hypophosphite, and sodium hypophosphite)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
|            |           (vi) Iodine                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
|            |           (vii) N-phenethyl-4-piperidone (NPP)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
|            |           (viii) Pseudoephedrine, its salts, optical isomers, and salts of optical isomers                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
|            |           (ix) Phenylpropanolamine, its salts, optical isomers, and salts of optical isomers                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
|            |           (x) Red phosphorus                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
|            |           (xi) White phosphorus (Other names: Yellow Phosphorus)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
|            |           (2) [Reserved]                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
| 1997-07-12 | (a) Each person required by section 302 of the act (21 U.S.C. 822) to obtain a registration to distribute, import, or export a combination ephedrine product is temporarily exempted from the registration requirement, provided that the person submits a proper application for registration on or before July 12, 1997.                                                                                                                                                                                                                                                                                                                                                                                                         |
| 1997-12-03 | (b) Each person required by section 302 of the Act (21 U.S.C. 822) to obtain a registration to distribute, import, or export a drug product that contains pseudoephedrine or phenylpropanolamine that is regulated pursuant to paragraph (1)(iv) of the definition of regulated transaction in &#167;&#8201;1300.02 of this chapter is temporarily exempted from the registration requirement, provided that the person submits a proper application for registration on or before December 3, 1997.The exemption will remain in effect for each person who has made such application until the Administration has approved or denied that application.                                                                            |
| 2000-07-24 | (c) Each person required by section 302 of the act (21 U.S.C. 822) to obtain a registration to distribute, import, or export GBL is temporarily exempted from the registration requirement, provided that the DEA receives a proper application for registration on or before July 24, 2000.                                                                                                                                                                                                                                                                                                                                                                                                                                       |
| 2001-12-17 | (d) Each person required by section 302 of the Act (21 U.S.C. 822) to obtain a registration to distribute, import, or export the List I chemicals red phosphorus, white phosphorus, and hypophosphorous acid (and its salts), is temporarily exempted from the registration requirement, provided that the person submits a proper application for registration on or before December 17, 2001.                                                                                                                                                                                                                                                                                                                                    |
| 2003-06-30 | (e) Each person required by section 302 of the Act (21 U.S.C. 822) to obtain a registration to distribute, import, or export regulated chemical mixtures which contain ephedrine, N-methylephedrine, N-methylpseudoephedrine, norpseudoephedrine, phenylpropanolamine, and/or pseudoephedrine, pursuant to &#167;&#167;&#8201;1310.12 and 1310.13, is temporarily exempted from the registration requirement, provided that DEA receives a proper application for registration or application for exemption on or before June 30, 2003.                                                                                                                                                                                            |
| 2005-02-14 | (f) Except for chemical mixtures containing the listed chemicals in paragraph (e) of this section, each person required by section 302 of the Act (21 U.S.C. 822) to obtain a registration to distribute, import, or export regulated chemical mixtures, pursuant to &#167;&#167;&#8201;1310.12 and 1310.13, is temporarily exempted from the registration requirement, provided that DEA receives a proper application for registration or application for exemption on or before February 14, 2005.                                                                                                                                                                                                                              |
| 2007-06-22 | (h) Each person required under 21 U.S.C. 822 and 21 U.S.C. 957 to obtain a registration to manufacture, distribute, import, or export regulated N-phenethyl-4-piperidone (NPP), including regulated chemical mixtures pursuant to &#167;&#8201;1310.12, is temporarily exempted from the registration requirement, provided that DEA receives a proper application for registration or application for exemption for a chemical mixture containing NPP pursuant to &#167;&#8201;1310.13 on or before June 22, 2007.                                                                                                                                                                                                                |
| 2007-08-31 | (i) Each person required by section 302 of the Act (21 U.S.C. 822) to obtain a registration to manufacture, distribute, import, or export regulated iodine, including regulated iodine chemical mixtures pursuant to &#167;&#167;&#8201;1310.12 and 1310.13, is temporarily exempted from the registration requirement, provided that the Administration receives a proper application for registration or application for exemption for a chemical mixture containing iodine on or before August 31, 2007.                                                                                                                                                                                                                        |
| 2007-08-24 | (j) Each person required by section 302 of the Act (21 U.S.C. 822) to obtain a registration to manufacture, distribute, import, or export regulated chemical mixtures which contain ephedrine, and/or pseudoephedrine, pursuant to Sections 1310.12 and 1310.13, is temporarily exempted from the registration requirement, provided that DEA receives a properly completed application for registration or application for exemption on or before August 24, 2007.                                                                                                                                                                                                                                                                |
| 2010-07-29 | (k)(1) Each person required by sections 302 or 1007 of the Act (21 U.S.C. 822, 957) to obtain a registration to manufacture, distribute, import, or export regulated GBL-containing chemical mixtures, pursuant to sections 1310.12 and 1310.13, is temporarily exempted from the registration requirement, provided that DEA receives a properly completed application for registration or application for exemption on or before July 29, 2010.                                                                                                                                                                                                                                                                                  |
| 2011-05-02 | (l)(1) Each person required under sections 302 and 1007 of the Act (21 U.S.C. 822, 957) to obtain a registration to manufacture, distribute, import, or export regulated ergocristine and its salts, including regulated chemical mixtures pursuant to &#167;&#8201;1310.12, is temporarily exempted from the registration requirement, provided that DEA receives a properly completed application for registration or application for exemption for a chemical mixture containing ergocristine and its salts pursuant to &#167;&#8201;1310.13 on or before May 2, 2011.                                                                                                                                                          |
| 2011-07-05 | (m)(1) Each person required by Sections 302 or 1007 of the Act (21 U.S.C. 822, 957) to obtain a registration to manufacture, distribute, import, or export regulated chemical mixtures which contain red phosphorus, white phosphorus, hypophosphorous acid (and its salts), pursuant to &#167;&#167;&#8201;1310.12 and 1310.13, is temporarily exempted from the registration requirement, provided that DEA receives a properly completed application for registration or application for exemption on or before July 5, 2011.                                                                                                                                                                                                   |
| 2017-08-14 | (n)(1) Each person required under sections 302 and 1007 of the Act (21 U.S.C. 822, 957) to obtain a registration to manufacture, distribute, import, or export regulated alpha-phenylacetoacetonitrile (APAAN) and its salts, optical isomers, and salts of optical isomers, including regulated chemical mixtures pursuant to &#167;&#8201;1310.12, is temporarily exempted from the registration requirement, provided that the DEA receives a properly completed application for registration or application for exemption for a chemical mixture containing alpha-phenylacetoacetonitrile (APAAN) and its salts, optical isomers, and salts of optical isomers, pursuant to &#167;&#8201;1310.13 on or before August 14, 2017. |


